These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation. DeVos JM; Gaber AO; Knight RJ; Land GA; Suki WN; Gaber LW; Patel SJ Kidney Int; 2012 Sep; 82(5):598-604. PubMed ID: 22622504 [TBL] [Abstract][Full Text] [Related]
48. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation. Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767 [TBL] [Abstract][Full Text] [Related]
49. Prospective Monitoring of Donor-specific Anti-HLA Antibodies After Intestine/Multivisceral Transplantation: Significance of De Novo Antibodies. Kubal C; Mangus R; Saxena R; Lobashevsky A; Higgins N; Fridell J; Tector AJ Transplantation; 2015 Aug; 99(8):e49-56. PubMed ID: 25769071 [TBL] [Abstract][Full Text] [Related]
50. The Role of Donor-Specific Antibodies in Intestinal Transplantation: Experience at the University of California Los Angeles and Literature Review. Cheng EY; Kaneku H; Farmer DG Clin Transpl; 2014; ():153-9. PubMed ID: 26281140 [TBL] [Abstract][Full Text] [Related]
51. Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients. Crespo E; Cravedi P; Martorell J; Luque S; Melilli E; Cruzado JM; Jarque M; Meneghini M; Manonelles A; Donadei C; Lloberas N; Gomà M; Grinyó JM; Heeger P; Bestard O Kidney Int; 2017 Jul; 92(1):201-213. PubMed ID: 28274484 [TBL] [Abstract][Full Text] [Related]
52. Frequency of Human Leukocyte Antigens and Donor Specific Antibodies in Long-Term Living Donor Kidney Transplantation. Alagoz S; Seyahi N Transplant Proc; 2019 Sep; 51(7):2302-2307. PubMed ID: 31358448 [TBL] [Abstract][Full Text] [Related]
53. Pre-existing donor-specific antibodies are detrimental to kidney allograft only when persistent after transplantation. Caillard S; Becmeur C; Gautier-Vargas G; Olagne J; Muller C; Cognard N; Perrin P; Braun L; Heibel F; Lefebre F; Renner V; Gachet C; Moulin B; Parissiadis A Transpl Int; 2017 Jan; 30(1):29-40. PubMed ID: 27678382 [TBL] [Abstract][Full Text] [Related]